Clinical Trials
662
Active:8
Completed:195
Trial Phases
6 Phases
Early Phase 1:9
Phase 1:93
Phase 2:63
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (455 trials with phase data)• Click on a phase to view related trials
Not Applicable
236 (51.9%)Phase 1
93 (20.4%)Phase 2
63 (13.8%)Phase 4
31 (6.8%)Phase 3
23 (5.1%)Early Phase 1
9 (2.0%)Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers
Not Applicable
Not yet recruiting
- Conditions
- Healthy Volunteers
- Interventions
- Drug: Psilocybin and D-SerineDiagnostic Test: Physical ExaminationDiagnostic Test: Vital signsDiagnostic Test: ECG testDiagnostic Test: Comprehensive Blood PanelDiagnostic Test: Complete Blood CountDiagnostic Test: UrinalysisDiagnostic Test: Urine Toxicology ScreenDiagnostic Test: A pregnancy Urine testDiagnostic Test: ElectroencephalogramDiagnostic Test: Plasma Amino Acid LevelsDiagnostic Test: Plasma Inflammation MarkersDiagnostic Test: Plasma Brain-Derived Neurotrophic FactoOther: Mini International Neuropsychiatric InterviewOther: Family Psychiatric History AssessmentOther: Beck Depression InventoryOther: State-Trait Anxiety InventoryBehavioral: Profile of Mood StatesBehavioral: Subjective Units of Distress ScaleOther: Five-Dimensional Altered States of Consciousness questionnaireBehavioral: Integration
- First Posted Date
- 2025-07-23
- Last Posted Date
- 2025-07-31
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 10
- Registration Number
- NCT07079930
- Locations
- 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel, Jerusalem, Israel
The Effects of TTNS, TTNS Combined With PHUS, and Conventional Therapy With PHUS in the Treatment of PFC.
Not Applicable
Recruiting
- Conditions
- ConstipationConstipation - Functional
- First Posted Date
- 2025-07-22
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 64
- Registration Number
- NCT07077044
- Locations
- 🇮🇱
Hadassah Hebrew University Hospital, Jerusalem, Israel
Colostrum from MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial.
Phase 1
Completed
- Conditions
- COVID 19
- Interventions
- Biological: Colostrum Nasal SprayOther: Water for injection
- First Posted Date
- 2025-03-04
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 43
- Registration Number
- NCT06857318
- Locations
- 🇮🇱
Hadassah Hebrew University, Jerusalem, Israel
Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals
Phase 4
Recruiting
- Conditions
- HIV Infected IndividualsOsteopenia
- Interventions
- Drug: Zoledronic Acid 5 mg/Bag 100 ml Inj
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 110
- Registration Number
- NCT06762730
- Locations
- 🇮🇱
Rambam Medical Center, Hiafa, Israel
🇮🇱Hadassah Hebrew University Medical Center, Jerusalem, Israel
🇮🇱Sheba Medical Center, Tel Hashmer, Israel
The Expression of CD24 "do-not-eat-me" Signal in Cholangiocarcinoma
Active, not recruiting
- Conditions
- Cholangiocarcinoma
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Hadassah Medical Organization
- Target Recruit Count
- 50
- Registration Number
- NCT06707025
- Locations
- 🇮🇱
Hdassah Hospital, Jerusalem, Israel
- Prev
- 1
- 2
- 3
- 4
- 5
- 133
- Next
News
No news found